Furthermore, DLL4/NOTCH1 signaling blocked AKT activation, decreased proliferation and reversed EndoMT in BMPR2-silenced PAECs and ECs from IPAH patients. This evidence concerns the gene AKT1 and idiopathic pulmonary arterial hypertension.